Algernon Pharmaceuticals Announces Launch of Rights Offering

Diamond Therapeutics Announces FDA-authorized Clinical Trial of Low-Dose Psilocybin in Collaboration...

Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine...

Psychedelic Bulletin #133: Ketamine Clinics Close with Potential Repercussions for PAT...

Psychedelics Weekly – Field Trip Health Closes Five Clinics, Legalization Bills...

PT399 – Vital Psychedelic Conversations

Clearmind Medicine Submits IND Application to FDA for its Proprietary CMND-100...

MYDECINE INNOVATIONS GROUP ANNOUNCES COMMON SHARE SUBSCRIPTION AGREEMENT

Reunion Sues Mindset, Claims it Copied RE104

Field Trip Health & Wellness to Close Clinics in 5 Locations

Load more